Aspira Women's Health Inc. (AWHL) SEC Filings & Financial Intelligence
Aspira Women's Health Inc. (AWHL) is a publicly traded company on the OTC, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AWHL
CIK: 926617
Exchange: OTC
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerNicole Cunneen
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-08 | 4 | 0001493152-26-045579 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0000926617-26-000054 | View SEC Doc Filr Page |
| 4/A | 2026-07-17 | 2026-06-16 | 4/A | 0001493152-26-033814 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-06-16 | 4 | 0001493152-26-033384 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-06 | 8-K | 0000926617-26-000052 | View SEC Doc Filr Page |
| 3 | 2026-07-15 | 2026-04-27 | 3 | 0001493152-26-033355 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-07 | 2026-06-17 | 8-K/A | 0000926617-26-000050 | View SEC Doc Filr Page |
| D | 2026-06-22 | — | D Filing | 0001104659-26-076151 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-17 | 8-K | 0000926617-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0000926617-26-000045 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-11 | — | SCHEDULE 13D/A Filing | 0001493152-26-028278 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001493152-26-027952 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | 8-K | 0000926617-26-000042 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-29 | — | DEFA14A | 0000926617-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2025-09-19 | 4 | 0001493152-26-026359 | View SEC Doc Filr Page |
| 4/A | 2026-05-29 | 2025-09-17 | 4/A | 0001493152-26-026346 | View SEC Doc Filr Page |
| 4/A | 2026-05-29 | 2025-09-17 | 4/A | 0001493152-26-026345 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-20 | 8-K | 0000926617-26-000037 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0000926617-26-000033 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-26 | 8-K | 0000926617-26-000029 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0000926617-26-000027 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0000926617-26-000025 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-17 | DEF 14A | 0000926617-26-000023 | View SEC Doc Filr Page |
| 10-K | 2026-04-01 | 2025-12-31 | 10-K | 0000926617-26-000020 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NT 10-K | 0000926617-26-000016 | View SEC Doc Filr Page |